ArticleClinical and translational allergy2023

Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat.

Danny M Cohn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.